ACTA1 and cancer: We found that the higher levels of α-SMA, a cancer (carcinoma)-associated fibroblasts (CAF) marker, positive stromal cells were detected in Exo treatment group, and Exo-c-Jun-KO treatment showed lower levels of α-SMA (Figures 5C, D).